Risk Stratification of Patients Admitted to Hospital with Covid-19 Using the ISARIC WHO Clinical Characterisation Protocol: Development and Validation of the 4C Mortality Score

Authors

  • Yang Jianshe Department of Gastroenterology of Third Affiliated Hospital, the Chinese University of Hong Kong, Shenzhen, China.
  • Kang Li Department of Gastroenterology the Longgang District Peoples' Hospital of Shenzhen, No.53 Aixin Road, Longgang District, Shenzhen 518172, China.

DOI:

https://doi.org/10.9734/bpi/mono/978-81-19039-63-0/CH20

Keywords:

COVID-19, SARS-CoV-2, risk stratification, 4C mortality score

Abstract

Few models can perfectly predict coming events. Even having encountered the disastrous pandemic of SARS-COV-2, and the complex disease COVID-19 it initiated. Antiviral drugs and vaccines available now have very limited effects, and the novel strategies on the way have uncertain results. In addition, COVID-19 has greatly changed our views, from formerly being a predominantly pulmonary disease to a systematic syndrome affecting many organs. Furthermore, many more factors are tightly correlated with COVID-19, such as age, comorbidities, psychic situation, public healthy polices, even the politic aspects. Management and prevention partially under the guidance of a pragmatic risk stratification tool to predict mortality in patients admitted to hospital with COVID-19 become more and more important.

Published

2023-02-09

How to Cite

Yang Jianshe, & Kang Li. (2023). Risk Stratification of Patients Admitted to Hospital with Covid-19 Using the ISARIC WHO Clinical Characterisation Protocol: Development and Validation of the 4C Mortality Score. Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2, 250–252. https://doi.org/10.9734/bpi/mono/978-81-19039-63-0/CH20

Issue

Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2

Section

Contents